A 4852
Reported from Assembly Comm
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
- New Jersey
- House / Assembly
- Introduced May 4, 2026
- Session 222
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
New Jersey’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
3 actions-
Reported from Assembly Comm. as a Substitute, 2nd Reading
-
Transferred to Assembly State and Local Government Committee
-
Introduced, Referred to Assembly Health Committee